LYVE1 was identified as a major receptor for HA (hyaluronane, extracellular matrix glycosaminoglycan) on the lymphatic vessel wall. The deduced amino acid sequence of LYVE1 predicts an integral membrane polypeptide...
LYVE1 was identified as a major receptor for HA (hyaluronane, extracellular matrix glycosaminoglycan) on the lymphatic vessel wall. The amino acid sequence derived from LYVE1 predicted a 322-type full membrane polypeptide type I residues similar to the CD44 HA receptor with a 212-residue extracellular domain containing a single Link module, the prototypic HA binding domain of the Link protein superfamily. Like CD44, the LYVE1 molecule binds soluble HAs and immobilized HAs. However, unlike CD44, the LYVE1 molecule colocates with HA on the luminal side of the lymphatic vessel wall and is completely absent from the blood vessels. Therefore, LYVE1 is the first lymph specific HA receptor to be characterized and is a unique and powerful marker for the lymphatic vessels themselves. LYVE1 is a Type I integral membrane glycoprotein. LYVE-1 is primarily expressed on the endothelium of the lymphatic vessels and is likely to be involved in regulating the trafficking of leukocytes and tumour cells to the lymph nodes. Lymphatic vasculature forms a second circulatory system that drains extracellular fluid from tissues and provides an exclusive environment in which immune cells can meet and respond to foreign antigens. Several molecules were identified as markers for lymphatic lheendothelium that include LYVE1, PALE, VEGFR3 and podoplanin. Among the diseases associated with LYVE1 dysfunction, there is complete androgen insensitivity syndrome.
Sensitivity
Sensitivity of dosage: 8 pg/ml.
Measurement range
Dose range: 8.19 to 2.000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Coefficient of intradose variation < 10%, interdose < 12%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17727973 |
| Specifications |
| Accession number | Q9Y5Y7 |
| Dose range | 8.19 to 2.000 pg/ml |
| Sensitivity of the dosage | 8 pg/ml |
| Conjugate | Biotin |
| Product type | ELISA |
| Type of sample | Plasma, Serum, Surnatant |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 10894 |
| Gene symbol(s) | Lyve1 |
| Coefficient of inter-dose variation | < 12% |
| Coefficient of intra-dose variation | < 10% |
| Contents of kits | 96-well pre-coated plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids |
| Marker or dye | HRP |
| Quantity | 10 x 96 tests |
| Regulatory status | RUO |
| Target | LYVE1 |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 1 μl-Serum, 1 μl-Surnatant, 100 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EHLYVE1X10 |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3002 12 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.